Introduction
Inositol 1,4,5-trisphosphate (InsP 3 )-mediated Ca 2ϩ release from intracellular stores controls a variety of cellular processes including cell growth, fertilization, secretion, smooth muscle contraction, and neuronal signaling (Berridge, 1993) . The InsP 3 receptor type I (InsP 3 R-I), the most well studied of the three InsP 3 R isoforms, is involved in the regulation of neuronal functions such as long-term potentiation and depression (Nagase et al., 2003) .
The InsP 3 R-I is regulated by endogenous compounds such as InsP 3 , Ca 2ϩ , and ATP, and modulated by associated proteins such as calmodulin and chromogranin (Ehrlich et al., 1994; Thrower et al., 2003; Bezprozvanny, 2005; Choe and Ehrlich, 2006) . The InsP 3 R-I is also regulated by posttranslational modifications. For example, phosphorylation by PKA (protein kinase A) or tyrosine kinases increases channel activity, and the functional sites of phosphorylation have been identified (Jayaraman et al., 1996; Wojcikiewicz and Luo, 1998; Tang et al., 2003) . The InsP 3 R-I is also posttranslationally modified by N-glycosylation, and the sites of modification are known (Michikawa et al., 1994) . However, functional changes have not been identified with this modification.
Another class of posttranslational modification is O-GlcNAcylation, a type of O-linked glycosylation in which ␤-Nacetylglucosamine (O-GlcNAc) is added to serine or threonine residues (Wells and Hart, 2003) . Classical O-linked and N-linked glycosylation occurs in the secretory pathway, with the enzymes involved residing in the endoplasmic reticulum and the Golgi apparatus, and glycosylation occurring on lumenal residues. This irreversible type of glycosylation regulates protein folding, targeting, and turnover (Helenius and Aebi, 2004) . In the case of O-GlcNAcylation, O-GlcNActransferase (OGT) and O-GlcNAcase, the enzymes that add and remove O-GlcNAc to proteins, reside in the cytoplasm and the nucleus, and O-GlcNAcylation occurs on the nucleoplasmic and cytoplasmic domains of proteins. OGT and O-GlcNAcase have been cloned, and O-GlcNAcase has been characterized for in vitro use (Kreppel et al., 1997; Gao et al., 2001) .
O-GlcNAcylation is an abundant, dynamic, and inducible modification that shares common characteristics with protein phosphorylation. Proteins modified by O-GlcNAc include transcription factors, signaling components, and metabolic enzymes. Changes in the level of O-GlcNAcylation of several of these proteins are known to regulate their activity by modulating either protein phosphorylation, protein-protein interactions, or subcellular localization (Wells and Hart, 2003) . O-GlcNAcylation has also been shown to play a role in the regulation of InsP 3 -mediated Ca 2ϩ signaling. Cardiomyocytes of diabetic rats show altered Ca 2ϩ transients that can be restored to normal by decreasing the cellular O-GlcNAcylation level (Clark et al., 2003) . Cardiomyocytes show an elevation of cytoplasmic Ca 2ϩ in response to the InsP 3 -generating agonist angiotensin II. This response can be blocked by inducing an increase in protein O-GlcNAcylation (Nagy et al., 2006) .
Here, we demonstrate for the first time that the InsP 3 R-I is modified by O-GlcNAc. Moreover, we show that the O-GlcNAc modification regulates the InsP 3 R-I at the single-channel level: addition of the O-GlcNAc group has a functional effect on the channel. InsP 3 -induced Ca 2ϩ release decreases with O-GlcNAcylation and increases with de-O-GlcNAcylation. This effect is specific for InsP 3 R-I, because there is no functional effect of O-GlcNAc on the ryanodine receptor (RyR). We also show for the first time that cerebellar interneurons have an InsP 3 -dependent increase in intracellular Ca 2ϩ and that this increase can be modulated by O-GlcNAc. We speculate that this may be partially responsible for improper neuronal signaling under conditions such as diabetes, when cellular UDP-GlcNAc levels are elevated (Robinson et al., 1995) .
Materials and Methods
All procedures for animal use were in accordance with guidelines approved by the host institutions where experimental work was performed, namely the University of Paris 5 and Yale University.
InsP 3 R-I immunoprecipitation and purification. Mice cerebella (PelFreez Biologicals, Rogers, AR) were homogenized in 10 vol of buffer A (50 mM Tris-HCl, 1 mM EDTA, 1 mM 2-␤-mercaptoethanol, pH 8.3, and protease inhibitors). After centrifugation (1000 ϫ g for 10 min at 4°C), the supernatant was further centrifuged at 100,000 ϫ g for 30 min. The pellet was then resuspended in lysis buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 1% Triton X-100, pH 8.3, and protease inhibitors) and incubated for 30 min at 4°C. After centrifugation (16,000 ϫ g for 10 min at 4°C) the supernatant containing the solubilized receptors was incubated at 4°C with anti-InsP 3 R-I (affinity purified from rabbit polyclonal antiserum directed against the 19 C-terminal residues of the mouse InsP 3 R-I) for 1 h, and then for an additional 12-24 h with protein A-Sepharose beads. The immune complexes were then isolated by centrifugation (500 ϫ g for 2 min) and washed three times with ice-cold PBS. The pellet of beads was then resuspended in sample buffer, and the protein was analyzed by SDS-PAGE.
When immunoprecipitating the receptor from cultured cells, the cells were harvested with HBSS (Invitrogen, Carlsbad, CA) and centrifuged at 750 ϫ g for 3 min at 4°C. The cells were then incubated in lysis buffer, and the procedure described above was followed from that point on.
To partially purify the InsP 3 R-I from mouse cerebella, tissue was solubilized in 1% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), and then this mixture was passed over a heparin affinity column as described previously (Thrower et al., 2003) .
Culture and treatments of SH-SY5Y and DT40 B cells. SH-SY5Y cells were cultured in a 1:1 mixture of F-12 Ham's and Minimum Essential Medium, supplemented with 10% fetal bovine serum, 1% Minimum Essential Medium nonessential amino acids, and penicillin/streptomycin (Invitrogen). DT40 B cells were grown in RPMI 1640 supplemented with 10% fetal calf serum, 0.05 mM 2-mercaptoethanol, 1% chicken serum, glutamine, and penicillin/streptomycin. Cells were cultured in a watersaturated atmosphere at 37°C and 5% CO 2 . To induce an increase in O-GlcNAc, n-acetylglucosamine (GlcNAc) or O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) (kindly provided by G. W. Hart, Johns Hopkins University, Baltimore, MD) was added to the growth medium. PUGNAc was added at a final concentration of 200 M for 24 h. GlcNAc was added at a final concentration of 8 mM for 72 h or with 8 mM mannitol as an osmotic protector.
Cerebellar and cellular microsomal preparation. Mouse or rat cerebella (Pel-Freez Biologicals) were homogenized using a Teflon-glass homogenizer in a homogenization buffer containing 250 mM sucrose, 5 mM HEPES/KOH, pH 7.4, 1 mM EGTA, 1 mM DTT, and protease inhibitors. The homogenate was then centrifuged at 1000 ϫ g for 5 min at 4°C. The supernatant was saved and the pellet was resuspended in homogenization buffer and centrifuged again at 1000 ϫ g for 5 min. The pellet was then discarded, and the pooled supernatants were centrifuged at 8000 ϫ g for 10 min at 4°C. The pellet was discarded, and the supernatant was centrifuged at 100,000 ϫ g for 75 min. The final pellet was resuspended in homogenization buffer without EGTA and snap frozen in liquid nitrogen.
When preparing microsomes from cells, the cells were homogenized by passage through a 27 gauge needle. Then, the procedure described above was followed starting with the centrifugation at 8000 ϫ g for 10 min.
Western blot analysis. Protein samples were resolved by SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The blots were then incubated overnight at 4°C with monoclonal antibodies that recognized the O-linked sugar bond; RL2 (isotype IgG1 from Affinity BioReagents, Golden, CO) or CTD 110.6 (isotype IgM from Covance, Richmond, CA). After washing, blots were incubated for 1 h at room temperature with HRP-linked goat anti-mouse antibody (Bio-Rad, Hercules, CA). Blots were then visualized using ECL (Pierce Biotechnology, Rockford, IL). Blots to be reprobed were previously stripped of antibodies using Re-Blot Plus kit (Chemicon International, Temecula, CA). One hour incubation at room temperature with polyclonal antibodies that recognized InsP 3 R-I (Johenning et al., 2002) was followed by washing and incubation for 1 h at room temperature with HRP-linked goat antirabbit antibody (Bio-Rad). ECL was again used to visualize the blot. In some cases, the receptor was identified before the O-linked sugar bond; the order of visualization did not alter the results.
Removal of N-linked sugars or O-GlcNAc. Heparin-purified InsP 3 R-I was treated with N-glycosidase F, endoglycosidase H (New England BioLabs, Beverly, MA), or recombinant O-GlcNAcase (␤-N-acetylglucosaminidase; product no. A6805; Sigma, St. Louis, MO) following the manufacturer's protocol. The ability to remove O-linked sugars was assessed by examining the treated samples with antibodies that recognized the O-linked sugar bond as described above (see Western blot analysis).
Preparation of mouse cerebellar cytosol. Cerebellar cytosol was isolated by homogenization and centrifugation as described previously (Marshall et al., 2003) . Briefly, mouse cerebella were homogenized in ice-cold buffer consisting of 250 mM sucrose, 10 mM Tris, 1 mM MgCl 2 , pH 7.6, and protease inhibitors. The homogenate was then centrifuged at 600 ϫ g for 10 min. The pellet was discarded, and the supernatant was centrifuged at 20,000 ϫ g for 10 min to obtain the crude cytosol. The cytosol was then desalted by polyethylene glycol (PEG) precipitation to increase the OGT activity of the sample. The cytosol was mixed with 2 vol of 30% ice-cold PEG solution (25 mM HEPES, 10 mM MgCl 2 , pH 7.2), and after being vortexed, the sample was centrifuged at 20,000 ϫ g for 20 min to precipitate proteins. The supernatant was discarded, and the pellet was resuspended in transferase assay buffer containing 25 mM HEPES, 10 mM MgCl 2 , and 1 mM EDTA, pH 7.
Single-channel recordings. InsP 3 R-I from cerebella microsomes were incorporated into planar lipid bilayers and recorded as described previously (Bezprozvanny et al., 1991; Thrower et al., 2003) . The experiments were performed with a 250 mM HEPES-Tris solution, pH 7.35, on the cis-and a 250 mM HEPES, 53 mM Ba(OH) 2 solution, pH 7.35, on the trans-side of the bilayer (1 ml chamber). For the InsP 3 R-I, single-channel activity was recorded in the presence of 0.5 mM ATP, 2 M InsP 3 , 8 M ruthenium red, and 0.3 M free Ca 2ϩ on the cytoplasmic side of the InsP 3 R (cis-side of the bilayer; 1 ml chamber), unless otherwise specified. For the RyR, single-channel activity was recorded in the presence of 0.5 mM ATP and 0.3 M free Ca 2ϩ , but in the absence of InsP 3 (which activates the InsP 3 R) and ruthenium red (which blocks RyR). To elicit channel de-O-GlcNAcylation, a mixture of 4 l of O-GlcNAcase (Sigma) plus 1 l of 5ϫ manufacturer reaction buffer was added directly to the cis-side of the bilayer without stirring. To elicit O-GlcNAcylation of the channel, a mixture of 1 l of UDP-GlcNAc plus 4 l of desalted cerebella cytosol was added directly over the membrane at the cis-side. After 1 min, the reactions were stopped by stirring for 30 s. Experiments were recorded under voltage-clamp conditions, the data were amplified (BC-525C; Warner Instrument, Hamden, CT), filtered at 1 kHz, digitized, and directly transferred to a computer. The data were acquired and analyzed with pClamp (Molecular Devices, Union City, CA). At least 3 min of recordings at each condition in each experiment were used for calculation of open probability, open and closed times.
Calcium imaging of SH-SY5Y cells. SH-SY5Y cells were plated on 22 mm 2 glass coverslips, at 3-8 ϫ 10 5 cells per well of a six-well plate, and grown overnight. Cultures were supplemented for 72 h with 20 mM mannitol, 8 mM GlcNAc, or 20 mM glucose, as indicated.
Coverslips were incubated for 30 min in HEPES-buffered saline (HBS) containing 130 mM NaCl, 5 mM KCl, 1.25 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1 mM MgSO 4 , 20 mM HEPES, 6.9 mM glucose, pH 7.4, with NaOH, supplemented with 6 M fluo-4 AM (Invitrogen). Cells were washed with HBS, and placed in an imaging chamber (Warner Instrument) perfused with HBS on the stage of a Nikon (Tokyo, Japan) Diaphot fluorescence microscope. Fluo-4 was illuminated through a 40ϫ air objective from an Hg arc lamp and emission detected through a GFP (green fluorescent protein) filter cube to a cooled CCD camera (NeuroCCD-SM256; Red Shirt Imaging, Decatur, GA). After a baseline was established in HBS, InsP 3 -dependent Ca 2ϩ release was stimulated by perfusion of MgATPcontaining HBS, as indicated, to the chamber. Throughout fluo-4 loading and perfusion, HBS was supplemented with 20 mM mannitol (control), 8 mM GlcNAc, or 20 mM glucose (26.9 mM total), as indicated.
Data were collected using Neuroplex 7.0 (Red Shirt Imaging) at 1 Hz and analyzed using IGOR Pro 5.0. Cells were considered to have responded to ATP if ⌬F/F o was Ͼ0.1 after stimulation. Data are displayed as mean Ϯ SE.
Cerebellar slice preparation and electrophysiological recording of slices. Slices (180 m thick) were prepared from the vermis of cerebella taken from rats aged 11-15 d. Interneurons of the cerebellar molecular layer (MLIs) were identified as described previously (Llano and Gerschenfeld, 1993) . During recordings, the slices were perfused (1.5 ml/min) with a saline solution containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM glucose, equilibrated with a 95% O 2 /5% CO 2 mixture, pH 7.3. All experiments were performed at room temperature. Whole-cell recordings were performed with an intracellular recording solution containing the following (in mM): 140 K-gluconate, 5.4 KCl, 4.1 MgCl 2 , 9.9 HEPES-K, 0.36 Na-GTP, and 3.6 Na-ATP, pH 7.3. MLIs were held in whole-cell recording for Ͻ1 min using the above intracellular recording solution, supplemented with 200 M K ϩ salt of Oregon Green 488 BAPTA-1 (OG1) (Invitrogen) and 400 M caged Ins(1,4,5)P 3 (Calbiochem, La Jolla, CA). The patch pipette was then withdrawn, and fluorescence recording could begin after a few minutes of equilibration.
InsP 3 uncaging and calcium imaging in cerebellar slices. Digital fluorescence images were obtained using an excitation-acquisition system from TILL Photonics (Planegg, Germany). Briefly, to excite fluorescence of the Ca 2ϩ dye OG1, light from a 75 W Xenon lamp was focused on a scanning monochromator set at 488 nm and coupled, by a quartz fiber and a lens, to the microscope, equipped with a dichroic mirror and a high-pass emission filter centered at 505 and 507 nm, respectively. Images were acquired by a Peltier-cooled CCD camera (IMAGO QE; 1376 ϫ 1040 pixels; pixel size: 244 nm after 53ϫ magnification and 2 ϫ 2 binning) connected to a 12 bit A/D converter. Photolysis of D-myo-InsP 3 P4(5)-1-(2-nitrophenyl)ethyl ester (caged InsP 3 ) was achieved using a pulsed xenon arc lamp (Till Photonics). A high intensity (0.5-5 ms duration; 80 J) discharge of UV light (360 Ϯ 7.5 nm) was reflected onto the plane of focus using a dichroic mirror and Olympus (Tokyo, Japan) 60ϫ water immersion objective (numerical aperture, 0.9). Analysis of images was performed as described previously (Llano et al., 1997) using homemade routines within the IGOR programming environment (Wavemetrics, Lake Oswego, OR).
Results

The InsP 3 R-I is modified by O-GlcNAc
To determine whether O-GlcNAcylation is involved in regulation of the InsP 3 R-I channel, we first established that the InsP 3 R-I is O-GlcNAcylated using biochemical techniques. We immunoprecipitated the InsP 3 R-I from mouse cerebella and from SH-SY5Y cells using an antibody produced to recognize the InsP 3 R-I (Johenning et al., 2002) . Western blot analysis was performed using an antibody that recognizes O-GlcNAcylated proteins [RL2 (Snow et al., 1987) ]. The InsP 3 R-I band was identified from both samples by RL2 indicating that the receptor is O-GlcNAcylated (Fig. 1 A) . This immunoreactivity was specifically inhibited in the presence of 0.3 M GlcNAc (data not shown). Another antibody that recognizes GlcNAc in a ␤-O-glycosidic linkage to both serine and threonine, CTD110.6 , also identified InsP 3 R-I bands (data not shown).
Treatment of the InsP 3 R-I with O-GlcNAcase removes anti-OGlcNAc immunoreactivity
To confirm that the immunoreactivity detected was attributable to O-GlcNAcylation and not to N-glycosylation, which is known to be present on the InsP 3 R-I (Michikawa et al., 1994) , we partially purified the InsP 3 R-I by heparin affinity chromatography and treated it with N-glycosidase F, endoglycosidase H, or O-GlcNAcase. N-Glycosidase F and endoglycosidase H remove oligosaccharides from N-linked glycoproteins. After treating the purified proteins with N-glycosidase F or endoglycosidase H, Western blot analysis showed that the protein sample was still stained by RL2 (Fig. 1 B, lanes 2-5) . In contrast, treatment with O-GlcNAcase removed the anti-O-GlcNAc immunoreactivity ( Fig. 1 B, lane 6) . The anti-O-GlcNAc antibody was removed and the membrane was reprobed with anti-InsP 3 R-I showing homogeneous InsP 3 R-I staining in all lanes (Fig. 1 B) .
O-GlcNAc modification of the InsP 3 R-I can be modulated in vivo
When cells were incubated with the O-GlcNAcase inhibitor PUGNAc or with the hexosamine pathway intermediate GlcNAc, there was an increase in O-GlcNAcylation of numerous proteins (Haltiwanger et al., 1998) . We treated SH-SY5Y and DT40 B cells with PUGNAc, prepared microsomes, and analyzed the O-GlcNAc level with Western blot analysis. Initial staining with anti-InsP 3 R-I showed equivalent levels of protein on the sample from SH-SY5Y cells in control conditions and from cells incubated with PUGNAc (Fig. 2 A) . The membrane was then stripped of antibodies and reprobed with anti-O-GlcNAc. PUGNAc increased O-GlcNAcylation of many microsomal proteins including the InsP 3 R-I. This effect was also seen when examining the effects in DT40 B cells (Fig. 2 B) . Additionally, microsomes from DT40 B cells grown under control conditions were prepared with homogenization buffer supplemented with GlcNAc. It was found that this treatment also increased the level of O-GlcNAcylation (Fig. 2 B) , suggesting that endogenous O-GlcNAcase can remove GlcNAc from proteins during microsomal preparation. The addition of GlcNAc to the homogenization buffer provided excess substrate that was able to compete with the GlcNAc attached to proteins for binding to O-GlcNAcase, resulting in less removal of GlcNAc from proteins.
To confirm that the increase in O-GlcNAc immunoreactivity detected at the molecular weight of the InsP 3 R-I was attributable to increased O-GlcNAcylation of the InsP 3 R-I, we immunoprecipitated the InsP 3 R-I from DT40 B cells grown in media supplemented with GlcNAc. Initial staining with anti-InsP 3 R-I showed equivalent levels of receptor on the sample from DT40 B cells in control conditions and from cells incubated with GlcNAc (Fig.  2C, left panel) . After blotting for InsP 3 R-I, the membrane was stripped of antibodies and reprobed for O-GlcNAc. Under control conditions, the InsP 3 R-I is O-GlcNAcylated. The presence of multiple high molecular weight bands on the blot reflects the observation that the receptor is easily degraded and that it forms multimers under many conditions (Fig. 2C, right 
Addition and removal of O-GlcNAc have reciprocal functional effects on the InsP 3 R-I channel
To study the modulation of the InsP 3 R-I by O-GlcNAcylation, we incorporated mouse cerebellar InsP 3 R-I into planar lipid bilayers. Under control conditions, the presence of 0.5 mM ATP, 0.3 M free Ca 2ϩ , and 8 M ruthenium red (which blocks RyR) on the cytosolic (cis-) side of the bilayer elicited no channel activity (Fig. 3A, first trace) . Addition of 2 M InsP 3 elicited channel activity (Fig. 3A, second trace) with an open probability of 1.4 Ϯ 0.3% (n ϭ 4). To study the functional effect of de-OGlcNAcylation of the InsP 3 R-I, we applied O-GlcNAcase directly to the bilayer on the cis-side. Removal of the O-GlcNAc modification induced an increase of more than threefold in the open probability (Fig. 3A, third trace) , to 5 Ϯ 1% (n ϭ 4; p Ͻ 0.03 compared with control conditions) (Fig. 3C) . As a control, the solution containing O-GlcNAcase was boiled to denature it before addition to the bilayer chamber; no change in channel activity was detected under these conditions (data not shown).
To study the functional effect of O-GlcNAcylation on the InsP 3 R-I, we isolated mouse cerebellar cytosol (supplemental Fig.  1 , available at www.jneurosci.org as supplemental material) (Marshall et al., 2003) and used it as a source of OGT to modify the InsP 3 R-I inserted into planar lipid bilayers. Although OGT has been cloned and partially characterized (Kreppel et al., 1997; Lubas and Hanover, 2000) , the recombinant enzyme does not retain a high level of activity for in vitro use. Therefore, brain cytosol has been used as a reasonable source of OGT activity. Addition of 0.5 mM ATP and 0.3 M free Ca 2ϩ to the cis-side of the bilayer elicited no channel activity (Fig. 3B, first trace) . Addition of 2 M InsP 3 elicited channel openings with an open probability of 1.5 Ϯ 0.4% (n ϭ 4) (Fig. 3B, second trace) . Addition of cerebellar cytosolic extract and the GlcNAc donor UDP-GlcNAc directly to the lipid bilayer on the cis-side induced a dramatic reduction in channel activity (Fig. 3B, third trace) , to 0.08 Ϯ 0.01% (n ϭ 4; p Ͻ 0.02 compared with control conditions) (Fig.  3C) . As a control, UDP-GlcNAc without cerebella cytosol was added to the bilayer chamber; no change in channel activity was observed under these conditions (data not shown). To show the specificity of the modulation by O-GlcNAcylation, the addition of O-GlcNAcase directly to the cis-side of bilayers containing the RyR did not induce a detectable change in RyR channel activity (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material).
These reciprocal functional effects were also demonstrated by consecutive addition of cytosolic extract and UDP-GlcNAc followed by O-GlcNAcase to the same channel. Addition of 2 M InsP 3 in the presence of 0.5 mM ATP and 0.3 M free Ca 2ϩ elicits the opening of a channel with an open probability of 1.9 Ϯ 0.6% (n ϭ 2) (Fig. 4, first and second traces) . OGT modification of the channel was produced by addition of cytosolic extract and UDPGlcNAc directly to the lipid bilayer reducing the channel open probability to 0.1 Ϯ 0.02% (n ϭ 2) (Fig. 4, third trace) . The channel was then modified by O-GlcNAcase, which removed O-GlcNAc from the receptor and increased the open probability to 0.28 Ϯ 0.05% (n ϭ 2) (Fig. 4, fourth trace) . We believe the open probability did not return all the way to control values because the single addition of O-GlcNAcase to the bilayer was not able to remove all of the O-GlcNAc. It was not possible to make a second addition of O-GlcNAcase because of bilayer breakage.
Incubation with GlcNAc decreases whole-cell Ca
2؉ transients To investigate whether O-GlcNAcylation of the InsP 3 R-I also regulated the release of Ca 2ϩ in intact cells, we treated SH-SY5Y cells for 72 h with 8 mM GlcNAc to increase O-GlcNAcylation of the InsP 3 R-I (Fig. 5) and exposed them to extracellular ATP, known to stimulate InsP 3 production via P 2Y purinergic receptors. At 50 nM ATP stimulation, 86% of control cells responded, compared with 53% of GlcNAc-treated cells. At 100 nM ATP stimulation, all control cells responded, compared with only 75% of GlcNAc treated, whereas all cells of both groups responded with ⌬F/F o Ͼ 0.1 after 1 M ATP stimulation (Fig. 5B) . This suggests that, at submaximal levels of InsP 3 generation, pretreatment with GlcNAc increases the threshold for InsP 3 -induced Ca 2ϩ release, but that all treated cells are capable of responding, given sufficient stimulation.
Looking at the cells that did respond under each condition, we see that the responses are different. With 50 or 100 nM ATP stimulation, control and GlcNAc-treated cells respond similarly, whereas at maximal stimulation control cells exhibit a greater peak height than GlcNAc treated (0.84 Ϯ 0.01 vs 0.68 Ϯ 0.01; p Ͻ 10 Ϫ20 ) (Fig. 5C ). Combined with the data above, we conclude that GlcNAcylation leads to both a decrease in the sensitivity of cells to InsP 3 and to a reduced maximal Ca 2ϩ response because of InsP 3 stimulation. This suggests an effect at the cell level consistent with a decrease in InsP 3 R open probability as determined for single channels.
UDP-GlcNAc is generated physiologically through the hexosamine pathway, which branches off from the glycolytic intermediate fructose-6-phosphate. As such, the physiological concentration of UDP-GlcNAc is controlled by the glucose uptake of a cell, and it stands to reason that a high glucose environment can lead to increased O-GlcNAcylation of proteins (Robinson et al., 1995) . To investigate the role of this more physiological agonist, cells were incubated for 72 h in 26.9 mM glucose (6.9 mM in medium, supplemented with 20 mM) to induce increased O-GlcNAcylation. Similar to GlcNAc-treated cells, fewer highglucose-treated cells responded to low levels of ATP stimulation compared with control, whereas all cells responded at high agonist concentration (Fig. 5B ). In addition, the effect on peak height at different concentrations of ATP was even more pronounced for high-glucose-treated cells, with the mean peak height of responding cells only one-half that of control cells at 100 nM ATP stimulation (0.20 Ϯ 0.01 vs 0.49 Ϯ 0.03) (Fig. 5C ).
Addition of UDP-GlcNAc decreases calcium transients after uncaging InsP 3
To verify that the effect of GlcNAc on intact cell Ca 2ϩ signaling was attributable to InsP 3 R Ca 2ϩ release, we tested the effect of GlcNAc addition on the responses to release of InsP 3 in cerebellar interneurons. First, it was necessary to show that uncaging of InsP 3 in these cells was capable of inducing Ca 2ϩ release. Cells were preloaded with caged InsP 3 and the Ca 2ϩ indicator OG-1 (Fig. 6) . After a 4 min equilibration period, a UV flash was produced every 3 min to release InsP 3 , and Ca 2ϩ transients were monitored. The magnitude and shape of the responses were stable, diminishing by Ͻ20% over 19 min (Fig. 6 B, C) . The ability of uncaged InsP 3 to induce Ca 2ϩ release was inhibited by the addition of the InsP 3 R inhibitor 2-APB at 20 M (data not shown).
To test the effect of O-GlcNAcylation on the response to uncaging of InsP 3 , UDP-GlcNAc (10 mM) was added to the pipette during the preloading stage of the experiments. The first response after equilibration (at 4 min after introduction of the compound) was already reduced; the GlcNAc loaded cells showed a 72% reduction in the response to uncaging of InsP 3 (n ϭ 6; p Ͻ 0.001). The response to uncaging of InsP 3 at 4 and 7 min was stable in both the control cells and in cells loaded with GlcNAc (Fig. 6C) . Subsequent responses to uncaging of InsP 3 in control cells declined by ϳ20% in part because the amount of caged InsP 3 was decreasing in the cell. In contrast, the responses to uncaging of InsP 3 in GlcNAcloaded cells declined nearly to baseline (Fig. 6 B, C) , confirming a reduced sensitivity to InsP 3 in GlcNAc-treated cells.
Discussion
In this study, we show for the first time that the InsP 3 R-I is O-GlcNAcylated and that modification by O-GlcNAcylation has functional effects on the InsP 3 R-I channel. Addition of O-GlcNAc decreases the probability of channel opening and removal of O-GlcNAc increases channel activity, most likely by influencing the InsP 3 dependence of the InsP 3 R. The open probability of the InsP 3 R-I inserted into lipid bilayers was increased threefold when O-GlcNAcase was added to remove GlcNAc from the channel. The RyR is also O-GlcNAcylated, but removal of O-GlcNAc does not change its open probability. We also studied the effect of O-GlcNAc modification on the ability of cerebellar interneurons to produce InsP 3 -dependent Ca 2ϩ transients. We found that addition of UDP-GlcNAc decreased the ability of these cells to produce a Ca 2ϩ transient when InsP 3 was elevated, as predicted from the results obtained at the single-channel level. These results uncover a new mechanism of regulation of the InsP 3 R-I channel that is specific to this family of intracellular Ca 2ϩ release channel. InsP 3 R-I from several sources (mouse cerebella, SH-SY5Y cells, and DT-40 cells) were modified by GlcNAc. Both addition and removal of O-GlcNAc could be accomplished with the enzymes known to be present in the cytoplasm and nucleus (Kreppel et al., 1997; Gao et al., 2001) . The reactions are specific to O-linked sugars: O-GlcNAc immunoreactivity was removed when the InsP 3 R-I was treated with O-GlcNAcase but not when it was treated with enzymes that remove oligosaccharides from N-linked glycoproteins (Fig. 1 B) . Additional support for the specificity is that neither addition of boiled O-GlcNAcase nor of UDP-GlcNAc alone altered channel activity.
Other studies have demonstrated that O-GlcNAcylation regulates protein function either by altering enzyme activity, protein-protein interactions, subcellular localization, or protein phosphorylation. O-GlcNAc modification of glycogen synthase results in the retention of the enzyme in a glucose 6-phosphatedependent state and contributes to the reduced activation of the enzyme in insulin resistance (Parker et al., 2003) . O-GlcNAcylation of the activation domain of Sp1 blocks its in vitro and in vivo interactions with other Sp1 molecules and its transcriptional capability (Yang et al., 2001) . Microtubuleassociated Tau proteins are also modified by phosphorylation and O-GlcNAcylation. An increase in Tau protein phosphorylation level correlates with a decrease in O-GlcNAcylation level and with a reduced transfer of Tau into the nucleus (Lefebvre et al., 2003) .
To survive environmental, physiological, or chemical stress, cells must initiate signal transduction events that activate mechanisms that counteract apoptosis. Recent studies have found that conditions of stress generate a global increase in O-GlcNAc protein modification and that increasing O-GlcNAc levels protects cells (Zachara et al., 2004; Zachara and Hart, 2006) . It was also observed that O-GlcNAc regulates both the rate and extent of the stress-induced induction of heat shock proteins, providing a molecular basis to the cellular protection produced by O-GlcNAc (Zachara et al., 2004) . Ca 2ϩ -sensitive activation of caspases is an important pathway for the induction of apoptosis, and InsP 3 R-Isensitive Ca 2ϩ stores have been shown to play a role (Hajnoczky et al., 2000) . Our observation that O-GlcNAcylated InsP 3 R-I channels are low activity channels provides another possible explanation for how increased O-GlcNAcylation results in cellular protection against apoptosis.
Interestingly, an increase in O-GlcNAc level in myocardial cells has been associated with protection against stresses, such as ischemia and reperfusion, which lead to Ca 2ϩ overload. In a study of whole heart models, GlcNAc pretreatment elevated protein O-GlcNAcylation resulting in a marked increase in tolerance to injury caused by ischemia/reperfusion, characterized by a decreased release of lactate dehydrogenase (a marker of tissue injury) and improved contractile function (Liu et al., 2006) . The recent finding that increases in cytosolic Ca 2ϩ produced by InsP 3 generating agonists in cardiomyocytes are inhibited by increased O-GlcNAc levels (Nagy et al., 2006) is consistent with our observation that O-GlcNAcylated InsP 3 R-I channels are low activity channels. We also showed that O-GlcNAcylation of RyR does not regulate channel activity. In the failing human heart, expression of these two intracellular Ca 2ϩ release channels is regulated in opposite directions, where RyR is downregulated and InsP 3 R-I is upregulated (Go et al., 1995) . Together, these results indicate that Ca 2ϩ release through the InsP 3 R-I plays an important role in the cardioprotection provided by GlcNAc against myocardial Ca 2ϩ overload.
Diabetic cardiomyopathy is characterized by poor cardiac contractility linked to impaired sarcoplasmic reticulum Ca 2ϩ cycling, including reduced sarcoplasmic reticulum Ca 2ϩ content, decreased diastolic Ca 2ϩ uptake and systolic Ca 2ϩ release. Two recent papers have documented these alterations of Ca 2ϩ signaling in the diabetic cardiomyocyte and have linked them to increased levels of protein O-GlcNAcylation (Clark et al., 2003; Hu et al., 2005) . It was shown in diabetic heart models that protein O-GlcNAcylation is increased in both type I and type II diabetes (Hu et al., 2005) . Animals with streptozotocin-induced diabetes and hyperglycemia show a greatly increased concentration of the hexosamine metabolite UDP-GlcNAc (Robinson et al., 1995 O-GlcNAcase was shown to reduce cellular O-GlcNAcylation, enhance the diabetic cardiomyocyte transient, the sarcoplasmic reticulum Ca 2ϩ loading, and improve contractile function (Hu et al., 2005) . Our finding that increased O-GlcNAcylation of the InsP 3 R-I results in decreased Ca 2ϩ release is consistent with the diabetes-induced reduction in systolic Ca 2ϩ release and the enhancement of the diabetic cardiomyocyte transient resulting from O-GlcNAcase overexpression.
Brain damage is a recognized complication of diabetes. Data from epidemiological studies suggest that diabetes is a risk factor for neurocognitive dysfunction (Launer, 2005) . The pathophysiological basis of the dysfunction remains controversial with some studies identifying recurrent hypoglycemia as the primary cause of neuronal damage, whereas others associate these effects to chronic hyperglycemia (McNay et al., 2006; Wessels et al., 2006) . To further complicate the issue, recent reports indicate that, although brain dysfunction has been consistently reported in many diabetic patients, the literature fails to find serious and progressive global cognitive impairment (Ryan, 2006; Wessels et al., 2006) . In contrast, a recent study of the effect of recurrent hypoglycemia in cognitive function of a diabetic rat model concludes that recurrent hypoglycemia actually prevents the agerelated decline in hippocampus-associated cognitive function (McNay et al., 2006) . The remarkable implication of these data is that diabetic-associated changes in brain structure and function exist and can be measured, although only subtle neurocognitive dysfunction has been detected. A neuronal protective process must contribute to the relative preservation of neurocognitive function in the presence of damaged tissue. The brain is one of the tissues with the highest expression levels of OGT and O-GlcNAcase (Haltiwanger et al., 1992; Gao et al., 2001) . Protein O-GlcNAcylation is increased in both type I and type II diabetes (Hu et al., 2005) . Diabetes causes a reduction in the amplitude of InsP 3 -induced Ca 2ϩ release in primary and secondary nociceptive neurons (Clark et al., 2003; Kruglikov et al., 2004) . Because excessive cytosolic Ca 2ϩ is a well known mediator of neuronal death, increased O-GlcNAcylation of InsP 3 R-I leading to low channel activity would provide protection against apoptosis and associated changes in brain structure and function.
Growing evidence implicates Ca 2ϩ signaling disruptions in the etiology of neurodegenerative disorders like Alzheimer's disease (AD). Most cases of AD are sporadic, but ϳ10% are inherited (Thinakaran and Sisodia, 2006) . Mutations in presenilins 1 and 2 account for ϳ20 -50% of these forms of familial AD (FAD) (Tandon and Fraser, 2002) . Impaired Ca 2ϩ homeostasis and exaggerated InsP 3 -mediated Ca 2ϩ signals are observed in mice, Xenopus oocytes, and PC12 cells expressing presenilin mutations (Guo et al., 1996; Leissring et al., 1999; Stutzmann et al., 2004) . In a compelling study, Tu et al. (2006) show that wild-type, but not mutant presenilins, form low-conductance divalent-cationpermeable ion channels in planar lipid bilayers. The authors suggest that expression of mutant presenilins leads to loss of the normal endoplasmic reticulum Ca 2ϩ leak current and therefore cause an increased loading of the Ca 2ϩ store, which would explain the exaggerated InsP 3 -mediated Ca 2ϩ signals observed by previous studies with expression of presenilin mutations. Recently, it has also been observed that, in animal models of starved mice used to mimic the low glucose uptake/metabolism observed in the brains of individuals with AD, reduced glucose uptake resulted in decreased protein O-GlcNAcylation (Liu et al., 2004) . Therefore, another contributor to the enhancement of InsP 3 -evoked Ca 2ϩ release observed in FAD can be explained with our finding that decreased O-GlcNAcylation of the InsP 3 R-I in- creases Ca 2ϩ release. This new mechanism of regulation of the InsP 3 R-I may also prove relevant for understanding the potential role of Ca 2ϩ signaling disruptions in sporadic AD.
Under physiological conditions, the InsP 3 R-I channel couples activation of cell surface receptors to intracellular Ca 2ϩ release. Regulation of the InsP 3 R-I channel is thought to be a major component in the determination of the spatiotemporal characteristics of agonist-evoked Ca 2ϩ signals (Berridge, 1993) . Previous studies have shown that O-GlcNAcylation is a dynamic and inducible modification (for review, see Wells et al., 2001) . We have shown that O-GlcNAcylation of the InsP 3 R-I can be modulated both in vitro and in vivo. These modifications present a new mechanism of regulation of the InsP 3 R-I channel, which may emerge as a major player in the control of fundamental cellular processes regulated by changes in the cytosolic Ca 2ϩ concentration. 
